RCUS logo

Arcus Biosciences (RCUS) Company Overview

Profile

Full Name:

Arcus Biosciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 15, 2018

Indexes:

Not included

Description:

Arcus Biosciences Inc is a biopharmaceutical company operating in the clinical stage. It is developing immunotherapy for the treatment of cancer. The company focuses on the adenosine triphosphate (ATP)-adenosine pathway, which is a key factor in immunosuppression in the tumor microenvironment, to create and optimize differentiated low molecular weight candidate drugs for immuno-oncology. Its product pipeline includes Domvanalimab, Etrumadenant, AB680 and Zimberelimab. Arcus is conducting clinical trials for various types of cancer, such as prostate cancer, lung cancer, colorectal cancer, pancreatic cancer, and others. The company operates in a single segment, focusing on the development and commercialization of immunotherapeutic drugs. The company was founded in 2015 and is based in Hayward, California.

Key Details

Price

$9.41

Annual Revenue

$258.00 M(+120.51% YoY)

Annual EPS

-$3.14(+24.34% YoY)

Annual ROE

-59.77%

Beta

1.63

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Feb 25, 2025

Recent annual earnings:

Feb 25, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 26, 25 HC Wainwright & Co.
Buy
Feb 19, 25 B of A Securities
Neutral
Feb 18, 25 Morgan Stanley
Overweight
Feb 18, 25 HC Wainwright & Co.
Neutral
Nov 6, 24 HC Wainwright & Co.
Neutral
Oct 25, 24 Barclays
Overweight
Oct 24, 24 HC Wainwright & Co.
Neutral
Oct 21, 24 HC Wainwright & Co.
Neutral
Oct 8, 24 Wells Fargo
Overweight
Oct 7, 24 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Arcus Biosciences?
  • Does Arcus Biosciences pay dividends?
  • What sector is Arcus Biosciences in?
  • What industry is Arcus Biosciences in?
  • What country is Arcus Biosciences based in?
  • When did Arcus Biosciences go public?
  • Is Arcus Biosciences in the S&P 500?
  • Is Arcus Biosciences in the NASDAQ 100?
  • Is Arcus Biosciences in the Dow Jones?
  • When was Arcus Biosciences's last earnings report?
  • When does Arcus Biosciences report earnings?
  • Should I buy Arcus Biosciences stock now?

What is the ticker symbol for Arcus Biosciences?

The ticker symbol for Arcus Biosciences is NYSE:RCUS

Does Arcus Biosciences pay dividends?

No, Arcus Biosciences does not pay dividends

What sector is Arcus Biosciences in?

Arcus Biosciences is in the Healthcare sector

What industry is Arcus Biosciences in?

Arcus Biosciences is in the Biotechnology industry

What country is Arcus Biosciences based in?

Arcus Biosciences is headquartered in United States

When did Arcus Biosciences go public?

Arcus Biosciences's initial public offering (IPO) was on March 15, 2018

Is Arcus Biosciences in the S&P 500?

No, Arcus Biosciences is not included in the S&P 500 index

Is Arcus Biosciences in the NASDAQ 100?

No, Arcus Biosciences is not included in the NASDAQ 100 index

Is Arcus Biosciences in the Dow Jones?

No, Arcus Biosciences is not included in the Dow Jones index

When was Arcus Biosciences's last earnings report?

Arcus Biosciences's most recent earnings report was on Feb 25, 2025

When does Arcus Biosciences report earnings?

The next expected earnings date for Arcus Biosciences is May 8, 2025

Should I buy Arcus Biosciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions